Charlie's Holdings Reports $5.0 Million in Net Income Resulting in EPS of $0.02 for its Second Quarter 2025
Charlie's Holdings (OTCQB:CHUC), a premium vapor products company, reported significant financial improvements in Q2 2025. The company achieved net income of $5.0 million ($0.02 EPS), compared to a $1.0 million loss in Q2 2024, marking its first profitable quarter since Q2 2023. Revenue increased 25% to $2.5 million, excluding $6.5 million from PMTA asset sales.
Key developments include successful SBX product launch in 6 states, strategic PMTA product partnerships generating $6.5 million in income with potential additional $4.2 million in contingent payments, and plans to open a US manufacturing facility in Q4 2025. The company reduced Notes Payable by $2.8 million in H1 2025 and maintains 679 remaining PMTAs valued at over $650 million.
Charlie's Holdings (OTCQB:CHUC), azienda di prodotti vaporizzatori premium, ha registrato miglioramenti finanziari significativi nel secondo trimestre 2025. La società ha realizzato un utile netto di 5,0 milioni di dollari (EPS $0,02), rispetto a una perdita di 1,0 milione nel Q2 2024, segnando il primo trimestre in utile dal Q2 2023. I ricavi sono saliti del 25% a 2,5 milioni di dollari, esclusi 6,5 milioni derivanti dalla vendita di asset PMTA.
I punti chiave includono il successo del lancio del prodotto SBX in 6 stati, partnership strategiche sui prodotti PMTA che hanno generato 6,5 milioni di dollari di ricavi con ulteriori potenziali 4,2 milioni in pagamenti condizionati, e il progetto di aprire una struttura produttiva negli USA nel Q4 2025. La società ha ridotto le Note Payable di 2,8 milioni di dollari nella prima metà del 2025 e mantiene 679 PMTA rimanenti valutati oltre 650 milioni di dollari.
Charlie's Holdings (OTCQB:CHUC), empresa de productos de vapeo premium, reportó mejoras financieras significativas en el segundo trimestre de 2025. La compañía alcanzó un ingreso neto de $5.0 millones (EPS $0.02), frente a una pérdida de $1.0 millón en el Q2 2024, marcando su primer trimestre rentable desde el Q2 2023. Los ingresos aumentaron un 25% hasta $2.5 millones, excluyendo $6.5 millones procedentes de la venta de activos PMTA.
Entre los aspectos clave destacan el éxito del lanzamiento del producto SBX en 6 estados, asociaciones estratégicas de productos PMTA que generaron $6.5 millones en ingresos con otros potenciales $4.2 millones en pagos condicionados, y los planes para abrir una planta de fabricación en EE. UU. en el Q4 2025. La compañía redujo las Notas por Pagar en $2.8 millones en el H1 2025 y mantiene 679 PMTA restantes valoradas en más de $650 millones.
Charlie's Holdings (OTCQB:CHUC), 프리미엄 전자담배 제품 업체가 2025년 2분기에 재무 실적이 크게 개선되었다고 발표했습니다. 회사는 순이익 500만 달러(주당순이익 $0.02)를 기록했으며, 이는 2024년 2분기 100만 달러 손실에서의 전환으로 2023년 2분기 이후 첫 흑자 분기입니다. 매출은 PMTA 자산 매각으로 인한 650만 달러를 제외하고 25% 증가한 250만 달러를 기록했습니다.
주요 내용으로는 6개 주에서의 SBX 제품 출시 성공, 전략적 PMTA 제품 파트너십을 통한 650만 달러 수익 창출 및 추가로 발생할 수 있는 조건부 지급금 420만 달러 가능성, 그리고 2025년 4분기 미국 제조시설 설립 계획이 포함됩니다. 회사는 2025년 상반기에 지급어음(Notes Payable)을 280만 달러 감축했으며, 가치가 6억 5천만 달러가 넘는 679개의 PMTA를 보유하고 있습니다.
Charlie's Holdings (OTCQB:CHUC), société de produits de vapotage haut de gamme, a annoncé des améliorations financières significatives au T2 2025. La société a réalisé un résultat net de 5,0 millions de dollars (BPA 0,02 $), contre une perte de 1,0 million au T2 2024, marquant son premier trimestre bénéficiaire depuis le T2 2023. Le chiffre d'affaires a augmenté de 25% pour atteindre 2,5 millions de dollars, hors 6,5 millions provenant de la cession d'actifs PMTA.
Parmi les faits marquants : le lancement réussi du produit SBX dans 6 États, des partenariats stratégiques sur les produits PMTA générant 6,5 millions de dollars de revenus avec potentiellement 4,2 millions supplémentaires en paiements conditionnels, et le projet d'ouvrir une usine de fabrication aux États-Unis au T4 2025. La société a réduit ses billets à payer de 2,8 millions de dollars au S1 2025 et détient 679 PMTA restantes évaluées à plus de 650 millions de dollars.
Charlie's Holdings (OTCQB:CHUC), ein Unternehmen für Premium-Vapor-Produkte, meldete im zweiten Quartal 2025 deutliche finanzielle Verbesserungen. Das Unternehmen erzielte einen Nettoertrag von 5,0 Millionen US-Dollar (EPS 0,02 USD) gegenüber einem Verlust von 1,0 Million im Q2 2024 und verzeichnet damit das erste Gewinnquartal seit Q2 2023. Der Umsatz stieg um 25% auf 2,5 Millionen US-Dollar, ausgenommen 6,5 Millionen aus PMTA-Asset-Verkäufen.
Wesentliche Entwicklungen umfassen den erfolgreichen Markteintritt des SBX-Produkts in 6 Bundesstaaten, strategische PMTA-Produktpartnerschaften, die 6,5 Millionen US-Dollar Einnahmen generierten mit potenziell zusätzlichen 4,2 Millionen an konditionalen Zahlungen, sowie Pläne zur Eröffnung einer US-Fertigungsstätte im Q4 2025. Das Unternehmen hat die Verbindlichkeiten aus Schuldverschreibungen um 2,8 Millionen US-Dollar in H1 2025 reduziert und hält 679 verbleibende PMTAs im Wert von über 650 Millionen US-Dollar.
- First profitable quarter since Q2 2023 with $5.0 million net income
- Revenue growth of 25% year-over-year to $2.5 million (excluding PMTA sales)
- Strategic PMTA partnerships generated $6.5 million with potential $4.2 million additional payments
- Significant debt reduction with $2.8 million decrease in Notes Payable
- Portfolio of 679 remaining PMTAs valued at over $650 million
- Successful launch of SBX product line with planned expansion
- Gross margin declined to 26.1% from 38.1% year-over-year
- Operating expenses increased by 2% compared to Q2 2024
- Facing shipping delays and tariff costs impacting vapor products
- Regulatory challenges requiring shift to US manufacturing
First Profitable Quarter Since Q2 2023
COSTA MESA, CA / ACCESS Newswire / August 21, 2025 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported results for the three months ended June 30, 2025, and provided an update on recent business highlights.
Key Financial Highlights for Q2 2025 (compared with Q2 2024)
Not including
$6.5 million income from PMTA asset sales, revenue increased25% to$2.5 million Net income of
$5.0 million , from a loss of$1.0 million EPS of
$0.02 , from a loss of$0.01 $2.8 million reduction in Notes Payable for the six months ended June 30, 2025
Recent Business Highlights
Successful SBX introduction in 6 strategically advantaged states; roll-out planned for multiple regional convenience store chains in Q3 and Q4 2025
Initial PMTA Products Strategic Partnerships generated
$6.5 million of income with an additional$4.2 million in contingent payments possible over the next 12 months (imputed value of CHUC's 679 remaining PMTA products is more than$650 million )Company plans to open US manufacturing facility in Q4 2025 for filling of select product lines
Age-gating technology in development to prevent youth access to nicotine vapor products
Upgraded sales team from a solely account management-centric team to a skilled and driven sales team to acquire new customers while maintaining excellent service with our existing customers
Subsequent Event
On August 8, 2025, the Company entered into and closed on an additional PMTA asset sale for one additional PACHA synthetic product and related asset, bringing the total PMTA Products purchased by the buyer to sixteen. The purchase price for this latest PMTA asset was
Management Commentary
Ryan Stump, Charlie's Chief Operating Officer, explained, "We are thrilled to report that all our hard work, time, and investments into CHUC's PMTA portfolio has begun to pay dividends. With FDA Acceptance Filings for nearly 700 PMTAs, with a Company commitment to full regulatory compliance, and with our first sales of a handful of our 2022 PMTA Products, we believe that Charlie's has only scratched the surface of realizing the full monetary and strategic value of our PMTA portfolio. We believe Charlie's 679 remaining PMTAs, as a stand-alone asset, have a monetary value that far exceeds Charlie's current market cap."
Henry Sicignano III, Charlie's President, explained, "It is gratifying to see that our shift in strategy over the last two years has come together so successfully. We are enormously pleased with our return to profitability, with our success at eliminating the vast majority of the Company's debt, and with our excellent prospects for licensing our PMTA products to several key strategic partners in the industry." Sicignano continued, "What's more, we expect that, in the second half of 2025, organic sales of Charlie's non-nicotine SBX™ product line will take the spotlight. Even though we only began roll-out of SBX late in the second quarter, early results suggest that if we are able to manufacture and import as much product as the market demands, SBX sales - alone - could make 2025 a record year for Charlie's."
Planned Strategic Shift in Manufacturing
To eliminate significant inspection delays and tariff costs that have severely impacted vapor products shipments for the entire industry in recent months, Charlie's intends to launch a US-filled product line in late 2025. In addition to mitigating shipping delays and tariff costs, the US-filled line will enable Charlie's to meet new domestic manufacturing requirements that have been announced by large states. Texas is implementing a new law, Senate Bill 2024, effective September 1, 2025, that bans the sale and possession of certain vape products, including those manufactured or marketed as coming from China or certain other "adversary countries." Tennessee and other states have similar legislation pending. To sell and distribute products in these markets, Charlie's plans to launch a US-filled vapor product line in Q4 2025. The Company's new line will meet new domestic manufacturing requirements and will appeal, broadly, to adult consumers who prefer "Made in America" products.
Financial Results for the Three Months Ended June 30, 2025:
Revenue: For the three months ended June 30, 2025, not including
$6.5 million of income from PMTA asset sales, revenue was$2.5 million , an increase of$0.5 million , or25% , compared with$2.0 million for the three months ended June 30, 2024. The increase in revenue was primarily due to an increase in the sales of Charlie's nicotine-based and nicotine substitute vapor products and alternative products.Gross Profit: For the three months ended June 30, 2025, not including
$6.5 million of income from PMTA asset sales, gross profit was$0.7 million , a decrease of$0.1 million , or17% , compared with$0.8 million for the three months ended June 30, 2024. The resulting gross margin for the three months ended June 30, 2025 was26.1% , compared with38.1% for the three months ended June 30, 2024.Total Operating Expenses: For the three months ended June 30, 2025, total operating expenses, including general and administrative, sales and marketing and research and development costs, were
$1.5 million , an increase of2% , compared with the three months ended June 30, 2024.Net Income/Loss: For the three months ended June 30, 2025, net income was
$5.0 million , compared with a net loss of$1.0 million for the three months ended June 30, 2024. The increase in net income was primarily due to a large new strategic partner purchase of PMTA assets during the 2nd quarter of 2025.EPS: For the three months ended June 30, 2025, diluted earnings per share were
$0.02 , compared with a diluted loss per share of ($0.01) , for the three months ended June 30, 2024.For the six months ended June 30, 2025, Notes Payable were reduced by
$2.8 million .
About Charlie's Holdings, Inc.
Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.
For additional information, please visit Charlie's corporate website at: Chuc.com and the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.
Investors Contact:
IR@charliesholdings.com
Phone: 949-570-069
SOURCE: Charlie's Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
What were Charlie's Holdings (CHUC) Q2 2025 earnings results?
How much did Charlie's Holdings (CHUC) generate from PMTA asset sales in Q2 2025?
What is the value of Charlie's Holdings' remaining PMTA portfolio?
Why is Charlie's Holdings planning to open a US manufacturing facility?
How much debt did Charlie's Holdings reduce in the first half of 2025?
